Reaction Details Report a problem with these data
Target
Galectin-3
Ligand
BDBM455402
Substrate
n/a
Meas. Tech.
fluorescence anisotropy assay
Kd
7.00±n/a nM
Citation
 Zetterberg, F; Nilsson, U; Leffler, H; Pedersen, A; Schambye, H; Brimert, T; Johnsson, R 1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins US Patent  US10730902 Publication Date 8/4/2020 
Target
Name:
Galectin-3
Synonyms:
LEG3_HUMAN | LGALS3 | MAC2
Type:
Enzyme
Mol. Mass.:
26156.54
Organism:
Homo sapiens (Human)
Description:
P17931
Residue:
250
Sequence:
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI
  
Inhibitor
Name:
BDBM455402
Synonyms:
3,3′-Dideoxy-3-[4-(4-methylpiperazin-1-yl)-1H-1,2,3-triazol-1-yl]-3′-[4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1′-sulfanediyl-di-β-D-galactopyranoside | US10730902, Example 2
Type:
Small organic molecule
Emp. Form.:
C27H35F3N8O8S
Mol. Mass.:
688.676
SMILES:
CN1CCN(CC1)c1cn(nn1)C1C(O)[C@@H](CO)OC(S[C@@H]2OC(CO)[C@H](O)[C@@H](C2O)n2cc(nn2)-c2cc(F)c(F)c(F)c2)[C@@H]1O |r|
Structure:
Search PDB for entries with ligand similarity: